Artificial intelligence (AI) and machine learning (ML) tools offer an ultra-material-sparing approach to accelerate ...
The CNPV pilot program reduces review times from 10-12 months to 1-2 months, benefiting generics and biosimilars. Companies must align market access, manufacturing, and post-approval readiness with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback